ISoP Sky Background

International Society of Pharmacovigilance


Committed to safer use of medicines worldwide

What is ISoP?

The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…

Join ISoP Today
Mira Harrison, president of the International Society of Pharmacovigilance talks about the benefits and fees of becoming a member.

COVID-19 Information

ISoP Symposium

ISOP Boston 2017

ISoP-DSRU Mid-Year Meeting

10-11 May 2022 – Webinar
Beyond spontaneous reporting: integrating data from multiple sources to ensure medicines safety
READ MORENMPA CDR-ISoP-UMC

ISoP 2022

Eurasia Academy

ISoP Annual Meeting

20-23 September 2022

A New Era of Pharmacovigilance: Challenges and Opportunities
READ MORE
ISoP Annual Meeting, Verona 2021

ISoP Seminar

Eurasia Academy

ISoP Boston Seminar 2022

05-06 December 2022

Intelligent Automation in Pharmacovigilance
READ MOREISoP 2020 Boston

Patient Safety Day 2022

ISoP Patient Safety Day 2022

7-8 September

We are delighted to announce the third version of the free online event ISoP Patient Safety Day.

Join us for free webinars and activities with worldwide experts.

READ MORE

ISoP 2021

ISoP Oman

ISoP Annual Meeting

Muscat, Oman, 08-10 November 2021

Integrated Pharmacovigilance for Safer Patients

READ MORE
ISoP 2021 Muscat, Oman

Chapter and SIG Activities

For more information click below.

Mira Harrison-Woolrych President ISoP

President of ISoP

I am honoured and delighted to have been elected as President of ISoP – as announced on 28th October 2019 at our Annual General Meeting in Bogota – and am especially proud to be the first woman to ever hold this role in our professional society.

Mira Harrison‐Woolrych
President – International Society of Pharmacovigilance

Drug Safety

ISoP Official Journal

Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.